# Digital Precision Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/digital-precision-medicine

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.digipmc.com
- Total disclosed funding: $42M
- Latest round: Series C (Jan 22, 2024)
- Investors on record: 12

## About

Established in 2016 and based in Beijing, China, Digital Precision Medicine incubated in the Key Laboratory of Molecular Imaging of the Chinese Academy of Sciences, is an intraoperative precision optical molecular imaging product and technology development company. which has been supported by the National 973 Program and other national projects. It has obtained 1 U.S. invention patent and 12 national invention patents, and the series of products have obtained the national medical device registration certificate and CE EU certification. In 2021, it launched 4K series products. In January 2024, it raised a series C funding for over CNY 200 million.

The company's products are divided into Super Eye Series C2000, Smart Eye Series Z2000, and Smart Eye Series H2000, all of which are molecular imaging systems. They are endoscopic high-definition products that provide real-time fluoroscopic images during surgery and are used in open surgery as well as minimally invasive surgery.

The company will use the series C funding to enhance the R&D capability of optical molecular imaging products and expand sales channels.

## Funding rounds

- Series C, Jan 22, 2024, $28M — Rising Capital, Hyfinity Investments, DHLT Investment
- Series B, Sep 9, 2022, $14M — Baopu Capital, Gree Electric Appliances, Inc of Zhuhai
- Series B, Jul 19, 2022 — SB China Venture Capital, Risheng Chuangyuan Fund Management, Longmen Investment
- Series A, Oct 22, 2018 — Purple Cow Startups, China Reform Holdings Corporation, JC Capital
- Series A, Jul 10, 2018 — Purple Cow Startups, JC Capital, Cspark

## Investors

- Purple Cow Startups (https://capitalatlas.ai/funds/purple-cow-startups) — Series A
- JC Capital (https://capitalatlas.ai/funds/jc-capital) — Series A
- Cspark — Series A
- China Reform Holdings Corporation — Series A
- SB China Venture Capital (https://capitalatlas.ai/funds/sb-china-venture-capital) — Series B
- Risheng Chuangyuan Fund Management (https://capitalatlas.ai/funds/risheng-chuangyuan-fund-management) — Series B
- Longmen Investment (https://capitalatlas.ai/funds/longmen-investment) — Series B
- Baopu Capital (https://capitalatlas.ai/funds/baopu-capital) — Series B
- Gree Electric Appliances, Inc of Zhuhai (https://capitalatlas.ai/funds/gree-electric-appliances-inc-of-zhuhai) — Series B
- Rising Capital (https://capitalatlas.ai/funds/rising-capital) — Series C
- Hyfinity Investments (https://capitalatlas.ai/funds/hyfinity-investments) — Series C
- DHLT Investment (https://capitalatlas.ai/funds/dhlt-investment) — Series C